跳至主要内容
临床试验/NCT01930448
NCT01930448撤回不适用

Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1

St. Luke's-Roosevelt Hospital Center1 个研究点 分布在 1 个国家开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Change in Incretin Effect

研究概览

简要总结

Gastric bypass (GBP) and laparoscopic adjustable banding (AGB) are common procedures that can result in significant weight loss and significantly improve type 2 diabetes in 40-80% of cases. The mechanism and time course of these changes have not been well studied and are poorly understood. The primary aim of this study is to investigate the potential weight-independent mechanisms of diabetes remission after GBP, by comparing GBP and AGB subjects after similar weight loss.

详细描述

All participants will be tested before and then after 10 and 20-30% weight loss after either GBP or AGB surgery. Subjects will undergo an oral glucose tolerance test (OGTT) an isoglycemic intravenous glucose test (IVGT) to assess the incretin effect, a measure of insulin sensitivity by an intravenous insulin sensitivity test (IVGTT) and body composition measurements.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • obese type 2 diabetes individuals scheduled to undergo bariatric surgery by either gastric banding or gastric bypass surgery

排除标准

  • 未提供

结局指标

主要结局

Change in Incretin Effect

时间窗: Before surgery, 1, 12, and 24 months post

Effect of GBP and AGB on incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP)

次要结局

  • Change in Body Composition(Before surgery, 12, and 24 months post)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验